Abstract

A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications

Author(s): Warner Meredith, Tuder Dmitry

Issue: May/Jun 2014 - Volume 18, Number 3

Page(s): 182-188

Download in electronic PDF format for $75

Abstract

Pain is extremely common in the U.S. It is estimated that 116 million Americans suffer from chronic pain. Narcotics and opioid medications are heavily relied upon for the treatment of pain. Currently, there is an epidemic of opioid abuse and misuse in the U.S. and alternative methods for the treatment of pain are required. Topical compounded pain creams are thought to be one such alternative. The purpose of this study was to establish a baseline regarding the beliefs of community physicians on the safety and efficacy of these compounds. A survey was sent to practicing physicians in the U.S. regarding their prescribing behaviors for topical compounds, as well as their beliefs about the efficacy and safety of these medications. Eleven prescribing practitioners participated in this survey with a response rate of 78%. The results were compiled with basic statistical work (Excel). This survey demonstrated that at the time of the study, topical compound creams for the treatment of pain were commonly used in clinical practice; these creams were used for musculoskeletal pain and for neuropathic pain. It was also determined that the vast majority of practicing prescribers felt that compounded pain creams were more efficacious than mass-produced, U.S. Food and Drug Administration-approved creams marketed by large multi-national pharmaceutical companies. Most of the respondents felt that these compounds allowed them to reduce their narcotic prescriptions overall. In addition, the results demonstrated that the prescribers felt these compounds were safe for their patients. In this small survey of practicing prescribing providers regarding the use of topical compounds, we found that these medications were not only effective but also safe.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
May/Jun 2014 Pg. 182-188	A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications Author(s): Warner Meredith, Tuder Dmitry
May/Jun 2010 Pg. 200-203	Topical Medications for Orofacial Neuropathic Pain Author(s): Bramwell Bethany L
May/Jun 2010 Pg. 182-192	Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Mar/Apr 2024 Pg. 100-109	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014 Pg. 278-286	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jan/Feb 2002 Pg. 4-6	Clinical Nuggets and Pearls: Chronic Neuropathic Pain and Opioid Tolerance Author(s): Jones Marty
Mar/Apr 2016 Pg. 107-113	Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Author(s): Rabi Joseph
Mar/Apr 2024 Pg. 111-116	Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Jul/Aug 2015 Pg. 295-300	Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
May/Jun 2008 Pg. 182-190	Topical Treatment of Neuropathic Pain Author(s): Vadaurri Vince
May/Jun 2009 Pg. 182-190	Update on Managing Neuropathic Pain Author(s): McNulty Jack P, Muller George
Jan/Feb 2018 Pg. 19-24	Pain: Systematic Review of Pharmacy Compounding of Pain Medication Author(s): Shawaqfeh Mohammad S, Harrington Catherine
Nov/Dec 2016 Pg. 517-520	Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial Author(s): Rabi Joseph, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle
Nov/Dec 2007 Pg. 514-519	Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen Author(s): Zugerman Jessie Jean M, Reed Thomas C
Nov/Dec 2020 Pg. 446-448	NASEM Report on Compounded Topical Pain Creams Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 118-119	Safe Use of Topical Local Anesthetic Medications for Pain Management Author(s): Epshteyn Mikhail G, Pepin Steven M
Nov/Dec 2019 Pg. 496-503	Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy? Author(s): Shakshuki Ayah, Agu Remigius U
May/Jun 2009 Pg. 218-219	Safe Use of Topical Local Anesthetic Medications for Pain Management Author(s): Epshteyn Mikhail G, Pepin Steven M
Sep/Oct 2009 Pg. 400-403	Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications Author(s): Gilbert John A
Jul/Aug 2010 Pg. 310-314	Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Author(s): Christiansen Joel, White Lyndell